Alliance EAY191-A6: FOLFOX in combination with binimetinib as second-line therapy for patients with advanced biliary tract cancers (BTCs) with MAPK pathway alterations: A ComboMATCH treatment trial Meeting Abstract
| Authors: | Shergill, A.; Liao, C. Y.; Elsaid, M. I.; Al Baghdadi, T.; Ji, Y.; Feldman, D.; George, S.; O'Reilly, E. M.; Meyerhardt, J. A.; Berg, S. A.; Schwartz, G. K.; Munster, P. N.; Bekaii-Saab, T. S.; Abou-Alfa, G. K.; Shroff, R. T.; Shapiro, G. I. |
| Abstract Title: | Alliance EAY191-A6: FOLFOX in combination with binimetinib as second-line therapy for patients with advanced biliary tract cancers (BTCs) with MAPK pathway alterations: A ComboMATCH treatment trial |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557406191 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.TPS4196 |
| Notes: | Meeting Abstract: TPS4196 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
